ESMO Clinical Practice Guidelines

Establishing the highest standards of clinical practice is a collective effort of the whole oncology community. The ESMO Clinical Practice Guidelines, prepared and reviewed by leading experts, help you provide patients with the best care options.

Cancer research is constantly advancing. Evidence-based medicine transfers the results of that research into new standards and methods for clinical practice. Thanks to ESMO’s regularly updated Clinical Practice Guidelines the decisions you make every day are supported by the informed consensus of the leading experts in our profession.

New and Updated ESMO Clinical Practice Guidelines in 2017!

In addition to three new titles:

we have also updated the following six guidelines: 

ESMO Clinical Practice Guidelines News

Keep up to date with news about ESMO guidelines, including the latest CPG publications, updated recommendations, algorithms, pocket guidelines and MCBS grading

view detailsof ESMO Clinical Practice Guidelines News

ESMO Clinical Practice Guidelines: Breast Cancer

3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC3) • Primary Breast Cancer • 2nd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC2) • BRCA in Breast Cancer

view detailsof ESMO Clinical Practice Guidelines: Breast Cancer

ESMO Clinical Practice Guidelines: Cancers of Unknown Primary Site

Cancers of Unknown Primary Site

view detailsof ESMO Clinical Practice Guidelines: Cancers of Unknown Primary Site

ESMO Clinical Practice Guidelines: Endocrine and Neuroendocrine Cancers

Neuroendocrine Bronchial and Thymic Tumours • Neuroendocrine Gastroenteropancreatic Tumours

view detailsof ESMO Clinical Practice Guidelines: Endocrine and Neuroendocrine Cancers

ESMO Clinical Practice Guidelines: Gastrointestinal Cancers

Rectal Cancer • Biliary cancer • Gastric cancer • Oesophageal cancer • Cancer of the pancreas • Metastatic colorectal cancer • Anal cancer • Early colon cancer • Familial risk colorectal cancer • Hepatocellular carcinoma

view detailsof ESMO Clinical Practice Guidelines: Gastrointestinal Cancers

ESMO Clinical Practice Guidelines: Genitourinary Cancers

Cancer of the Prostate • Bladder Cancer • Renal Cell Carcinoma • Penile Carcinoma • Testicular Seminoma and Non-Seminoma

view detailsof ESMO Clinical Practice Guidelines: Genitourinary Cancers

ESMO Clinical Practice Guidelines: Gynaecological Cancers

Cervical cancer • Endometrial cancer • Gestational trophoblastic disease • Newly diagnosed and relapsed epithelial ovarian carcinoma • Non-epithelial ovarian cancer

view detailsof ESMO Clinical Practice Guidelines: Gynaecological Cancers

ESMO Clinical Practice Guidelines: Haematological Malignancies

Chronic myeloid leukaemia • Newly diagnosed and relapsed mantle cell lymphoma • Multiple myeloma • Newly diagnosed and relapsed follicular lymphoma • Extranodal diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma • Acute lymphoblastic leukaemia • Peripheral T-cell lymphomas • Diffuse large B cell lymphoma • Chronic lymphocytic leukaemia • Hairy cell leukaemia • Philadelphia chromosome-negative chronic myeloproliferative neoplasms • Myelodysplastic syndromes • Hodgkin's lymphoma • Primary cutaneous lymphoma • Acute myeloblastic leukaemia in adult patients • Waldenstrom's macroglobulinaemia • Gastric marginal zone lymphoma of MALT type

view detailsof ESMO Clinical Practice Guidelines: Haematological Malignancies

ESMO Clinical Practice Guidelines: Head and Neck Cancers

Nasopharyngeal Cancer • Squamous-Cell Carcinoma of the Head and Neck

view detailsof ESMO Clinical Practice Guidelines: Head and Neck Cancers

ESMO Clinical Practice Guidelines: Hereditary Syndromes

Prevention and Screening in BRCA Mutation Carriers and Other Breast/Ovarian Hereditary Cancer Syndromes

view detailsof ESMO Clinical Practice Guidelines: Hereditary Syndromes

ESMO Clinical Practice Guidelines: Lung and Chest Tumours

Early and locally advanced non-small-cell lung cancer • Metastatic non-small-cell lung cancer • Thymic epithelial tumours • Malignant pleural mesothelioma • Small-cell lung cancer

view detailsof ESMO Clinical Practice Guidelines: Lung and Chest Tumours

ESMO Clinical Practice Guidelines: Melanoma

Cutaneous Melanoma

view detailsof ESMO Clinical Practice Guidelines: Melanoma

ESMO Clinical Practice Guidelines: Neuro-Oncology

EANO and ESMO guidelines on leptomeningeal metastasis from solid tumours • High-grade malignant glioma 

view detailsof ESMO Clinical Practice Guidelines: Neuro-Oncology

ESMO Clinical Practice Guidelines: Sarcoma and GIST

Soft Tissue and Visceral Sarcomas • Bone Sarcomas • Gastrointestinal Stromal Tumours

view detailsof ESMO Clinical Practice Guidelines: Sarcoma and GIST

ESMO Clinical Practice Guidelines: Supportive and Palliative Care

Management of infusion reactions to systemic anticancer therapy • Management of toxicities from immunotherapy • Management of febrile neutropaenia • MASCC and ESMO consensus guidelines for the prevention of chemotherapy and radiotherapy-induced nausea and vomiting • Treatment of dyspnoea in advanced cancer patients • Central venous access in oncology • Management of oral and gastrointestinal mucosal injury • Management of refractory symptoms at the end of life and the use of palliative sedation • Advanced care planning in palliative care • Bone health in cancer patients • Cancer, fertility and pregnancy • Management of chemotherapy extravasation • Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy •  Management of cancer pain • Management of venous thromboembolism in cancer patients • Prevention of chemotherapy and radiotherapy-induced nausea • Erythropoiesis-stimulating agents in the treatment of anaemia in cancer patients • Haematopoietic growth factors

view detailsof ESMO Clinical Practice Guidelines: Supportive and Palliative Care